In re Spectrum Pharms. Inc. Securities Litigation, No. 16-cv-2279-RFP-GWF

The Rosen Law Firm was co-Lead Counsel in this consolidated class action in the U.S. District Court for the District of Nevada.  The complaint alleged violations of the Exchange Act in connection with the Company’s issuance of materially false and misleading business information.   Plaintiffs settled this action for $2.995 million in cash.

Scroll to Top